Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
Sayyed, Sufyan Ali
2010 • In Nephrology Dialysis Transplantation, 25 (6), p. 1811
Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10
Adhikary L, Chow F, Nikolic-Paterson DJ et al. Abnormal p38 mi-togen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 2004; 47: 1210-1222
Anders HJ, Vielhauer V, Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 2003; 63: 401-415
Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447: 407-412
Berthier CC, Zhang H, Schin M et al. Enhanced expression of JAK-STAT pathway members in human diabetic nephropathy. Diabetes 2009; 58: 469-477
Bhaumik SR, Smith E, Shilatifard A. Covalent modifications of his-tones during development and disease pathogenesis. Nat Struct Mol Biol 2007; 14: 813-8201008-16.2001; 414
Chow FY, Nikolic-Paterson DJ, Ma FY et al. Monocyte chemoattrac-tant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 2007; 50: 471-480
Chow FY, Nikolic-Paterson DJ, Ozols E et al. Monocyte che-moattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80
Eknoyan G. Obesity, diabetes, and chronic kidney disease. Curr Diab Rep 2007; 7: 449-453
Giunti S, Tesch GH, Pinach S et al. Monocyte chemoattractant pro-tein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008; 51: 198-207
Ha H et al. Nephrol Dial Transpl 2006; 21(Suppl 2): iv33
Hills CE, Al-Rasheed N, Al-Rasheed N et al. C-Peptide reverses TGF-{beta}1-induced changes in renal proximal tubular cells: implications for the treatment of diabetic nephropathy. Am J Physiol Renal Physiol 2009; 296: F614-F621
Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705
Kulkarni O, Pawar RD, Purschke W et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J Am Soc Nephrol 2007; 18: 2350-2358
Li Y, Reddy MA, Miao F et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-depen-dent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008; 283: 26771-26781
Miao F, Gonzalo IG, Lanting L et al. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004; 279: 18091-18097
Miao F, Smith DD, Zhang L et al. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 ly-sine 9 dimethylation: an epigenetic study in diabetes. Diabetes 2008; 57: 3189-3198
Miao F, Wu X, Zhang L et al. Histone methylation patterns are cell-type specific in human monocytes and lymphocytes and well maintained at core genes. J Immunol 2008; 180: 2264-2269
Ninichuk V, Clauss S, Kulkarni O et al. Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3′PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. Am J Pathol 2008; 172: 628-637
Ninichuk V, Kulkarni O, Clauss S et al. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Eur J Med Res 2007; 12: 351-355
Oldfield MD, Bach LA, Forbes JM et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001; 108: 1853-1863
Prigent C, Dimitrov S. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci 2003; 116: 3677-3685
Qian Y, Feldman E, Pennathur S et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-1445
Reddy MA, Villeneuve LM, Wang M et al. Role of the lysine-spe-cific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res 2008; 103: 615-623
Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?. Diabetologia 2008; 51: 714-725
Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J 1987; 1: 272-281
Schmid H, Boucherot A, Yasuda Y et al. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic ne-phropathy. Diabetes 2006; 55: 2993-3003
Tikoo K, Meena RL, Kabra DG et al. Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. Br J Pharmacol 2008; 153: 1225-1231
Villagra A, Cheng F, Wang HW et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 2009; 10: 92-100
Villeneuve LM, Reddy MA, Lanting LL et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory pheno-type of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 2008; 105: 9047-9052
Wade PA. Transcriptional control at regulatory checkpoints by his-tone deacetylases: molecular connections between cancer and chro-matin. Hum Mol Genet 2001; 10: 693-698
Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 2009; 9: 91-105
Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787
